Globus Medical, Inc. Class A (GMED) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Globus Medical, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.417 Welcome to Globus Medical's third quarter 2025 earnings call. 00:00:05.417 -- 00:00:10.783 At this time, all lines will be on mute and a Q&A session 00:00:10.783 -- 00:00:14.367 will be held after the prepared remarks. 00:00:14.367 -- 00:00:20.333 To ask a question during the session, you will need to press star 11 on your telephone. 00:00:20.333 -- 00:00:24.538 You will then hear an automated message advising your hand is raised. 00:00:24.538 -- 00:00:28.600 To withdraw your question, please press star 11 again. 00:00:28.600 -- 00:00:32.464 Please be advised that today's conference is being recorded. 00:00:32.464 -- 00:00:37.509 I will now turn the call over to Brian Kearns, Senior Vice President 00:00:37.509 -- 00:00:40.352 of Business Development and Investor Relations. 00:00:40.352 -- 00:00:43.553 Mr. Kearns, please go ahead. 00:00:44.115 -- 00:00:48.419 Thank you, Stephanie, and thank you, everyone, for being with us today. 00:00:48.419 -- 00:00:53.805 Joining today's call from Globus Medical will be Keith Feil, President and CEO, 00:00:53.805 -- 00:00:57.627 and Kyle Klein, Chief Financial Officer. 00:00:57.676 -- 00:01:02.501 This review is being made available via webcast accessible through the investor relations 00:01:02.501 -- 00:01:07.224 section of the Globus Medical website at www.globusmedical.com. 00:01:08.807 -- 00:01:13.572 Before we begin, let me remind you that some of the statements made during this review 00:01:13.572 -- 00:01:16.935 are or may be considered forward-looking statements. 00:01:16.935 -- 00:01:21.980 Our Form 10-K for the 2024 fiscal year and our subsequent filings with the 00:01:21.980 -- 00:01:24.963 Securities and Exchange Commission identify 00:01:24.963 -- 00:01:30.144 certain factors that co...